GWM
OPK icon

Geneos Wealth Management’s Opko Health OPK Stock Holding History

Geneos Wealth Management’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-401
Closed -$501 – 2595
2024
Q2 		$501 Buy
+401
New +$520 ﹤0.01% 2053
2024
Q1 		– Sell
-401
Closed -$606 – 2196
2023
Q4 		$606 Hold
401
– – ﹤0.01% 2074
2023
Q3 		$642 Buy
+401
New +$730 ﹤0.01% 2078
2021
Q2 		– Sell
-4,870
Closed -$19K – 3037
2021
Q1 		$19K Buy
+4,870
New +$23.3K ﹤0.01% 2109
2020
Q1 		– Sell
-40,000
Closed -$60K – 2575
2019
Q4 		$60K Hold
40,000
– – ﹤0.01% 1164
2019
Q3 		$83K Hold
40,000
– – 0.01% 962
2019
Q2 		$97K Hold
40,000
– – 0.01% 923
2019
Q1 		$104K Hold
40,000
– – 0.01% 854
2018
Q4 		$126K Hold
40,000
– – 0.01% 757
2018
Q3 		$138K Buy
40,000
+28,750
+256% +$153K 0.01% 781
2018
Q2 		$52K Sell
11,250
-34,000
-75% -$129K ﹤0.01% 1022
2018
Q1 		$143K Sell
45,250
-470,000
-91% -$1.89M 0.01% 633
2017
Q4 		$2.52M Sell
515,250
-92,500
-15% -$537K 0.23% 115
2017
Q3 		$4.17M Buy
607,750
+177,143
+41% +$1.12M 0.41% 68
2017
Q2 		$2.83M Buy
430,607
+124,626
+41% +$874K 0.29% 91
2017
Q1 		$2.45M Buy
305,981
+302,975
+10,079% +$2.55M 0.25% 101
2016
Q4 		$27K Sell
3,006
-248,250
-99% -$2.57M ﹤0.01% 1066
2016
Q3 		$2.66M Buy
251,256
+125,149
+99% +$1.25M 0.36% 69
2016
Q2 		$1.23M Buy
126,107
+125,847
+48,403% +$1.28M 0.18% 125
2016
Q1 		$2K Buy
+260
New +$2.38K ﹤0.01% 1677

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geneos Wealth Management's OPK Position: Q3 2024 in Review

Geneos Wealth Management sold out of Opko Health (OPK) in Q3 2024, closing a stake of 401 shares — an estimated $501 sold.

Geneos Wealth Management first reported a position in OPK in Q1 2016 and held it in 20 quarters. The position peaked at $4.17M in Q3 2017. 234 funds tracked by Wall St. Rank hold OPK as of Q3 2024.

  • Geneos Wealth Management reported no remaining Opko Health position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 401 Opko Health shares in Q3 2024, an estimated $501.
  • Geneos Wealth Management first reported a position in Opko Health in Q1 2016 and held it in 20 quarters.
  • Geneos Wealth Management's Opko Health position peaked at $4.17M in Q3 2017.
  • 234 funds tracked by Wall St. Rank held Opko Health as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.